Emerging Paradigms in Immunonutrition

Topics in Companion Animal Medicine

Volumn 26, Issue 1, 2011, Pages 25-32

  Satyaraj, Ebenezer ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Aging; Colostrums; CR; Cytokines; Immunosenecence; Natural stress; Nutritional immunology; Prebiotics; Probiotics; Vaccine response

Indexed keywords

EID: 79952784010     PISSN: 19389736     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tcam.2011.01.004     Document Type: Review

References (79)

1. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
2. Hoffmann J.A., Reichhart J.M. Drosophila innate immunity: an evolutionary perspective. Nat Immunol 2002, 3:121-126.
3. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
4. Karagiannides I., Pothoulakis C. Obesity, innate immunity and gut inflammation. Curr Opin Gastroenterol 2007, 23:661-666.
5. Fain J.N. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010, 2010:513948.
6. Akira S., Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003, 85:85-95.
7. Charriere G., Cousin B., Arnaud E., et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 2003, 278:9850-9855.
8. Khazen W., M'bika J.P., Tomkiewicz C., et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett 2005, 579:5631-5634.
9. Leoni M.C., Pizzo D., Marchi A. Adipocytokines: potential biomarkers for childhood obesity and anorexia nervosa. Minerva Pediatr 2010, 62:171-178.
10. Beisel W.R. History of nutritional immunology: introduction and overview. J Nutr 1992, 122:591-596.
11. Kipnis J., Derecki N.C., Yang C., et al. Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common?. Trends Immunol 2008, 29:455-463.
12. Romanyukha A.A., Rudnev S.G., Sidorov I.A. Energy cost of infection burden: an approach to understanding the dynamics of host-pathogen interactions. J Theor Biol 2006, 241:1-13.
13. Morein B., Abusugra I., Blomqvist G. Immunity in neonates. Vet Immunol Immunopathol 2002, 87:207-213.
14. Ungvari Z., Buffenstein R., Austad S.N., et al. Oxidative stress in vascular senescence: lessons from successfully aging species. Front Biosci 2008, 13:5056-5070.
15. Tausk F., Elenkov I., Moynihan J. Psychoneuroimmunology. Dermatol Ther 2008, 21:22-31.
16. Toman M., Faldyna M., Knotigova P., et al. Postnatal development of leukocyte subset composition and activity in dogs. Vet Immunol Immunopathol 2002, 87:321-326.
17. Gerber J.D., Brown A.L. Effect of development and aging on the response of canine lymphocytes to phytohemagglutinin. Infect Immun 1974, 10:695-699.
18. Somberg R.L., Tipold A., Hartnett B.J., et al. Postnatal development of T cells in dogs with X-linked severe combined immunodeficiency. J Immunol 1996, 156:1431-1435.
19. Lee H.H., Hoeman C.M., Hardaway J.C., et al. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med 2008, 205:2269-2280.
20. Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of ageing. J Pathol 2007, 211:144-156.
21. Mocchegiani E., Santarelli L., Costarelli L., et al. Plasticity of neuroendocrine-thymus interactions during ontogeny and ageing: role of zinc and arginine. Ageing Res Rev 2006, 5:281-309.
22. Pawelec G., Solana R. Immunosenescence. Immunol Today 1997, 18:514-516.
23. Makinodan T. Patterns of age-related immunologic changes. Nutr Rev 1995, 53:S27-S31.
24. Mocchegiani E., Giacconi R., Cipriano C., et al. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp Gerontol 2002, 37:349-357.
25. Vedhara K., Irwin M.R. Human Psychoneuroimmunology 2005, Oxford University Press, Oxford.
26. Kiecolt-Glaser J.K., McGuire L., Robles T.F., et al. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 2002, 53:83-107.
27. Kiecolt-Glaser J.K., Cacioppo J.T., Malarkey W.B., et al. Acute psychological stressors and short-term immune changes: what, why, for whom, and to what extent?. Psychosom Med 1992, 54:680-685.
28. Kiecolt-Glaser J.K., Glaser R., Gravenstein S., et al. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A 1996, 93:3043-3047.
29. Morag M., Morag A., Reichenberg A., et al. Psychological variables as predictors of rubella antibody titers and fatigue-a prospective, double blind study. J Psychiatr Res 1999, 33:389-395.
30. Vedhara K., Cox N.K., Wilcock G.K., et al. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999, 353:627-631.
31. Jabaaij L., van H.J., Vingerhoets J.J., et al. Modulation of immune response to rDNA hepatitis B vaccination by psychological stress. J Psychosom Res 1996, 41:129-137.
32. Kiecolt-Glaser J.K., Cacioppo J.T., Malarkey W.B., et al. Acute psychological stressors and short-term immune changes: what, why, for whom, and to what extent?. Psychosom Med 1992, 54:680-685.
33. Burns E.A., Lum L.G., Seigneuret M.C., et al. Decreased specific antibody synthesis in old adults: decreased potency of antigen-specific B cells with aging. Mech Ageing Dev 1990, 53:229-241.
34. Patriarca P.A. A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility. JAMA 1994, 272:1700-1701.
35. Cohen S., Tyrrell D.A., Smith A.P. Psychological stress and susceptibility to the common cold. N Engl J Med 1991, 325:606-612.
36. Kehrli M.E., Burton J.L., Nonnecke B.J., et al. Effects of stress on leukocyte trafficking and immune responses: implications for vaccination. Adv Vet Med 1999, 41:61-81.
37. Padgett D.A., Glaser R. How stress influences the immune response. Trends Immunol 2003, 24:444-448.
38. Mirani M., Elenkov I., Volpi S., et al. HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 2002, 169:6361-6368.
39. Ashwell J.D., Vacchio M.S., Galon J. Do glucocorticoids participate in thymocyte development?. Immunol Today 2000, 21:644-646.
40. Russo-Marie F. Macrophages and the glucocorticoids. J Neuroimmunol 1992, 40:281-286.
41. Shaywitz A.J., Greenberg M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999, 68:821-861.
42. Bengmark S. Immunonutrition-concluding remarks. Nutrition 1999, 15:57-61.
43. Brandtzaeg P., Halstensen T.S., Kett K., et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989, 97:1562-1584.
44. Brandtzaeg P., Johansen F.E. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005, 206:32-63.
45. Conley M.E., Brown P., Bartelt M.S. IgG subclass potential of surface IgM-negative and surface IgM-positive human peripheral blood B cells. Clin Immunol Immunopathol 1987, 43:211-222.
46. Murtaugh M.P., Foss D.L. Inflammatory cytokines and antigen presenting cell activation. Vet Immunol Immunopathol 2002, 87:109-121.
47. van Nevel C.J., Decuypere J.A., Dierick N., et al. The influence of Lentinus edodes (Shiitake mushroom) preparations on bacteriological and morphological aspects of the small intestine in piglets. Arch Tierernahr 2003, 57:399-412.
48. Pietrella D., Mazzolla R., Lupo P., et al. Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice. Infect Immun 2002, 70:6621-6627.
49. Holen E., Bjorge O.A., Jonsson R. Dietary nucleotides and human immune cells. II. Modulation of PBMC growth and cytokine secretion. Nutrition 2006, 22:90-96.
50. Saavedra J.M. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr Clin Pract 2007, 22:351-365.
51. Hannant D. Mucosal immunology: overview and potential in the veterinary species. Vet Immunol Immunopathol 2002, 87:265-267.
52. Diet and Human Immune Function 2004, Humana Press.
53. Gleeson M., Pyne D.B., McDonald W.A., et al. In-vivo cell mediated immunity in elite swimmers in response to training. J Sci Med Sport 2004, 7:38-46.
54. Cooke M.S., Evans M.D., Dizdaroglu M., et al. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003, 17:1195-1214.
55. Cline A.M., Radic M.Z. Apoptosis, subcellular particles, and autoimmunity. Clin Immunol 2004, 112:175-182.
56. Barger J.L., Walford R.L., Weindruch R. The retardation of aging by caloric restriction: its significance in the transgenic era. Exp Gerontol 2003, 38:1343-1351.
57. Pahlavani M.A. Influence of caloric restriction on aging immune system. J Nutr Health Aging 2004, 8:38-47.
58. Greeley E.H., Kealy R.D., Ballam J.M., et al. The influence of age on the canine immune system. Vet Immunol Immunopathol 1996, 55:1-10.
59. Massimino S., Kearns R.J., Loos K.M., et al. Effects of age and dietary beta-carotene on immunological variables in dogs. J Vet Intern Med 2003, 17:835-842.
60. Kim H.W., Chew B.P., Wong T.S., et al. Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopathol 2000, 74:315-327.
61. Kim H.W., Chew B.P., Wong T.S., et al. Modulation of humoral and cell-mediated immune responses by dietary lutein in cats. Vet Immunol Immunopathol 2000, 73:331-341.
62. Flickinger E.A., Fahey G.C. Pet food and feed applications of inulin, oligofructose and other oligosaccharides. Br J Nutr 2002, 87(Suppl 2):S297-S300.
63. Benyacoub J., Czarnecki-Maulden G.L., Cavadini C., et al. Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. J Nutr 2003, 133:1158-1162.
64. Artym J., Zimecki M., Paprocka M., et al. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol Lett 2003, 89:9-15.
65. Low P.P., Rutherfurd K.J., Gill H.S., et al. Effect of dietary whey protein concentrate on primary and secondary antibody responses in immunized BALB/c mice. Int Immunopharmacol 2003, 3:393-401.
66. Bounous G., Gervais F., Amer V., et al. The influence of dietary whey protein on tissue glutathione and the diseases of aging. Clin Invest Med 1989, 12:343-349.
67. Bounous G., Batist G., Gold P. Immunoenhancing property of dietary whey protein in mice: role of glutathione. Clin Invest Med 1989, 12:154-161.
68. Biswas P., Vecchi A., Mantegani P., et al. Immunomodulatory effects of bovine colostrum in human peripheral blood mononuclear cells. New Microbiol 2007, 30:447-454.
69. Shing C.M., Peake J., Suzuki K., et al. Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. J Appl Physiol 2007, 102:1113-1122.
70. Immune enhancement in dogs fed bovine colostrum supplemented diets 2010, Reynolds A&SE.
71. Immune enhancement in cats fed diets supplemented with bovine colostrum 2010, Gore A&SE.
72. Casserly I.P., Topol E.J. Convergence of atherosclerosis and Alzheimer's disease: cholesterol, inflammation, and misfolded proteins. Discov Med 2004, 4:149-156.
73. Ames B.N., Gold L.S. The causes and prevention of cancer: the role of environment. Biotherapy 1998, 11:205-220.
74. Ames B.N. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001, 475:7-20.
75. Kaput J., Swartz D., Paisley E., et al. Diet-disease interactions at the molecular level: an experimental paradigm. J Nutr 1994, 124:1296S-1305S.
76. Milner J.A. Molecular targets for bioactive food components. J Nutr 2004, 134:2492S-2498S.
77. Goldenberg M.M. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther 1999, 21:309-318.
78. Baselga J., Norton L., Albanell J., et al. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 1998, 58:2825-2831.
79. Touw D.J. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes. Drug Metabol Drug Interact 1997, 14:55-82.